Concord Biosciences
1986
FOUNDED
M&A
STATUS
101-200
EMPLOYEES
M&A
LATEST DEAL TYPE
7
FINANCING ROUNDS
2
INVESTMENTS
Description
Provider of contract research and chemical development services. The company's services offers comprehensive capabilities and conducts studies with all species commonly used in nonclinical research providing study information with insightful analysis enabling its clients in the Agricultural Chemicals industry with a comprehensive, integrated suite of services to accelerate drug development through all phases of drug development.
Website
Formerly Known As
Ricerca Biosciences
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Specialty Chemicals
Pharmaceuticals
Parent Company
Primary Office
- 10845 Wellness Way
- Concord, OH 44077
- United States
+1 (440) 000-0000
Concord Biosciences Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Concord Biosciences‘s full profile, request access.
Request full access to PitchBookConcord Biosciences Competitors (18)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vimta Labs | Corporation | Hyderabad, India | 0000 | |||
| 0000000 0000000000 | Private Equity-Backed | Billerica, MA | 00000 | 00.000 | 000000000 | 00.000 |
| 0000 | Corporation | Dublin, Ireland | 00000 | 00000 | 000000000 | 00000 |
| 000000 | Formerly PE-Backed | Princeton, NJ | 000 | 00000 | 000000&0 | 00000 |
| 00000000 | Formerly PE-Backed | Évreux, France | 0000 | 000000&0 |
Concord Biosciences Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 01-Aug-2010 | 00000 00000 00 | Drug Discovery | ||
| MDS (Discovery & Pre-clinical Operations) | 08-Mar-2010 | Buyout/LBO | 000.00 | Drug Delivery | 000 000000 |
Concord Biosciences Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000 | 01-Aug-2010 | 00000 00000 00 | Completed |
|
Concord Biosciences Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Concord Biosciences‘s full profile, request access.
Request full access to PitchBookConcord Biosciences Executive Team (11)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Clifford Croley | Chief Executive Officer |
10 Former Executives
You’re viewing 1 of 11 executives. Get the full list »